About Us subnavigation
 
You are here: Home → About Us → News and Media → 2009 News → MaRS Innovation selects umbilical cord stem cell technology from Samuel Lunenfeld Research Institute as its first commercialization opportunity

Send this page to somebody

Fill in the email address of your friend to send an email with the address.
Address info
(Required)
The e-mail address to send this link to.
(Required)
Your email address.
A comment about this link.